Human|B-GENE immunodeficiency|I-GENE virus|I-GENE type|I-GENE -|I-GENE 1|I-GENE Tat|I-GENE /|O co|B-GENE -|I-GENE activator|I-GENE acetyltransferase|I-GENE interactions|O inhibit|O p53Lys|O -|O 320|O acetylation|O and|O p53|B-GENE -|O responsive|O transcription|O .|O
Because|O Tat|B-GENE has|O been|O shown|O to|O interact|O with|O histone|B-GENE acetyltransferase|I-GENE domains|I-GENE of|O p300|B-GENE /|O cAMP|B-GENE -|I-GENE responsive|I-GENE element|I-GENE -|I-GENE binding|I-GENE protein|I-GENE (|O CREB|B-GENE )|O -|O binding|O protein|O and|O p300|B-GENE /|O CREB|B-GENE -|I-GENE binding|I-GENE protein|I-GENE -|I-GENE associated|I-GENE factor|I-GENE ,|O we|O have|O investigated|O whether|O Tat|B-GENE might|O alter|O p53|B-GENE acetylation|O and|O tumor|O suppressor|O -|O responsive|O transcription|O .|O
Further|O ,|O p53|B-GENE trans|O -|O activation|O of|O the|O 14|B-GENE -|I-GENE 3|I-GENE -|I-GENE 3varsigma|I-GENE promoter|I-GENE was|O markedly|O repressed|O by|O Tat|B-GENE -|O histone|B-GENE acetyltransferase|I-GENE interactions|O ,|O and|O p53|B-GENE acetylation|O by|O p300|B-GENE /|O CREB|B-GENE -|I-GENE binding|I-GENE protein|I-GENE -|I-GENE associated|I-GENE factor|I-GENE on|O residue|O Lys|O (|O 320|O )|O was|O diminished|O as|O a|O result|O of|O Tat|B-GENE -|I-GENE histone|I-GENE acetyltransferase|I-GENE binding|O in|O vivo|O and|O in|O vitro|O .|O
Tat|B-GENE also|O inhibited|O p53|B-GENE acetylation|O by|O p300|B-GENE in|O a|O dosage|O -|O dependent|O manner|O in|O vitro|O .|O
Finally|O ,|O HIV|O -|O 1|O -|O infected|O Molt|O -|O 4|O cells|O displayed|O reduced|O p53|B-GENE acetylation|O on|O lysines|O 320|O and|O 373|O in|O response|O to|O UV|O irradiation|O .|O
